MAPT and Alzheimer disease: Normal CSF Aβ in combination with increased p-tau is a finding sometimes seen in clinical settings.2 Because p-tau increases are suggested to be AD specific,4,5 and increases would not be expected in Aβ-negative individuals, this finding is challenging to interpret.